SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001399529-19-000010
Filing Date
2019-04-29
Accepted
2019-04-26 17:32:42
Documents
4
Period of Report
2019-06-20
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A drna-20190424xdef14a.htm DEF 14A 571562
2 dicernalogowithtrademarkfeb2.jpg GRAPHIC 22788
3 proxycardfinal001.jpg GRAPHIC 128881
4 proxycardfinal002.jpg GRAPHIC 130698
  Complete submission text file 0001399529-19-000010.txt   961742
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36281 | Film No.: 19773017
SIC: 2834 Pharmaceutical Preparations